Skip to content

Clinical trials

Phase 2 Glioma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 2 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20112
20131
20141
20161
20172
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Novartis Pharmaceuticals2
Celgene1
Eli Lilly and Company1
Fore Biotherapeutics1
Hoffmann-La Roche1
Incyte Corporation1
Istituto Clinico Humanitas1
Meyer Children's Hospital IRCCS1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma14
Glioblastoma6
Central Nervous System Neoplasms5
Oligodendroglioma5
Astrocytoma4
Brain Neoplasms4
Neoplasms3
Biliary Tract Neoplasms2
Gastrointestinal Stromal Tumors2
Gliosarcoma2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.